US Bancorp’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-47
| Closed | -$501 | – | 4348 |
|
|
2024
Q4 | $501 | Hold |
47
| – | – | ﹤0.01% | 4015 |
|
|
2024
Q3 | $597 | Sell |
47
-123
| -72% | -$1.56K | ﹤0.01% | 3915 |
|
|
2024
Q2 | $2.85K | Buy |
170
+36
| +27% | +$604 | ﹤0.01% | 3628 |
|
|
2024
Q1 | $2.01K | Hold |
134
| – | – | ﹤0.01% | 3711 |
|
|
2023
Q4 | $2.01K | Buy |
+134
| New | +$2.01K | ﹤0.01% | 3692 |
|
|
2022
Q1 | – | Sell |
-605
| Closed | -$6K | – | 4163 |
|
|
2021
Q4 | $6K | Buy |
605
+209
| +53% | +$2.07K | ﹤0.01% | 3577 |
|
|
2021
Q3 | $6K | Buy |
396
+215
| +119% | +$3.26K | ﹤0.01% | 3576 |
|
|
2021
Q2 | $3K | Sell |
181
-1,294
| -88% | -$21.4K | ﹤0.01% | 3740 |
|
|
2021
Q1 | $29K | Sell |
1,475
-435
| -23% | -$8.55K | ﹤0.01% | 2851 |
|
|
2020
Q4 | $35K | Buy |
1,910
+659
| +53% | +$12.1K | ﹤0.01% | 2654 |
|
|
2020
Q3 | $24K | Buy |
1,251
+918
| +276% | +$17.6K | ﹤0.01% | 2709 |
|
|
2020
Q2 | $9K | Buy |
333
+48
| +17% | +$1.3K | ﹤0.01% | 3072 |
|
|
2020
Q1 | $5K | Buy |
285
+138
| +94% | +$2.42K | ﹤0.01% | 3205 |
|
|
2019
Q4 | $5K | Buy |
147
+11
| +8% | +$374 | ﹤0.01% | 3238 |
|
|
2019
Q3 | $3K | Hold |
136
| – | – | ﹤0.01% | 3362 |
|
|
2019
Q2 | $5K | Hold |
136
| – | – | ﹤0.01% | 3295 |
|
|
2019
Q1 | $5K | Hold |
136
| – | – | ﹤0.01% | 3256 |
|
|
2018
Q4 | $6K | Sell |
136
-34
| -20% | -$1.5K | ﹤0.01% | 3175 |
|
|
2018
Q3 | $8K | Buy |
+170
| New | +$8K | ﹤0.01% | 3206 |
|